Zydus Wellness Ltd Q1 FY2026 Concall Summary

Key Takeaways

• Seasonal hit masks structural strength: A shorter summer and unseasonal rains crushed Glucon D and Nycil, dragging overall volume growth to near-flattish. Excluding seasonal brands, the company delivered strong double-digit growth, and the non-seasonal portfolio remained robust.
• Gross margin dipped on mix, not on cost pressure: A 73 bps gross margin decline was driven by the lower saliency of high-margin seasonal brands, even as most other brands expanded gross margins. Cumulative 361 bps expansion over FY'24 and FY'25 provides a buffer.
• PAT decline is non-cash noise: The 13.4% PAT drop was primarily driven by amortization of intangibles from the Rite Bite acquisition and deferred tax impacts, not operational weakness. The company returned to a net cash positive position during the quarter.
• Rite Bite is outperforming: The acquired Naturell business continues to beat earlier estimates, with Rite Bite daily bars leading performance and strengthening the company's position in the high-growth better-for-you snacking category.
• What to watch next quarter: Whether the seasonal portfolio normalizes as the monsoon impact fades, the pace of gross margin recovery as mix improves, and any early traction signals from new launches like Nutralite cheese and Complan Viemax.

Seasonal Portfolio: The Quarter's Drag

• Glucon D: Category declined for the quarter as the summer season was cut short by early and prolonged monsoon conditions. The Glucon D Activors electrolyte energy drink has been rolled out nationally and is performing as expected under a revised distribution strategy aligned with weather-driven demand patterns.
• Nycil: Sustained a temporary dip due to early monsoons but maintained its number one position with 33.3% market share. Management noted that historically Nycil has managed well even in difficult seasons, but this quarter's rainy season was unusually deep and prolonged.
• Operating leverage dependency: Seasonal brands are critical for operating leverage and deliver disproportionate gross margin contribution. Management stated the business is "not yet" immune to seasonal impacts, so a weak summer quarter directly compresses profitability.
• Timing of impact: Most of the seasonal damage was absorbed in Q1; July and August represent a much smaller portion of the seasonal business, limiting further downside.

Tarun Arora: "I am not imagining a situation that we will be immune to seasonal brands not performing. It does impact us because they are a very critical part of our portfolio... immune to seasonal impacts not yet."

Non-Seasonal Portfolio: The Growth Engine

• EverYuth: Delivered a "phenomenal continued run" with sustained double-digit growth driven by innovation, product excellence, and strong distribution. The brand has expanded its user base year after year and maintained momentum from the prior year into Q1.
• Sugar Free: Sugar Free Delight delivered encouraging results with deeper distribution and health-conscious snacking trends driving momentum. Sugar Free Green continued to outperform, reflecting strong consumer affinity for natural alternatives and sustained volume-led growth.
• Nutralite: Core fat spread continued to drive momentum. New portfolio additions including value-added dairy and spreads, mayonnaise, branded butter, and ghee have played out as per expectations and ahead of budgets. Chocolate spread has not kept to promise but remains very small.
• Rite Bite Max Protein: The brand delivered robust growth with daily bars leading performance. Management described it as "probably by far the largest brand in bars in this space" and noted it does very well in general trade. Envisaged growth of 25%+ over the next 4 to 5 years, with current momentum running much higher than accounted for.
• Volume reality: Excluding seasonal brands, the company delivered strong double-digit growth on both volume and value. Adding seasonal brands back for organic growth makes the overall figure near-flattish.

Category Dynamics & Strategic Bets

• HFD category under structural pressure: The nutrition drink category declined 2.6% at MAT level with continued softness across key metrics. Management acknowledged that the relevance of HFD as a single source of nutrition has "dialed down" as consumers seek various other ways of getting nutrition. In the medium to long term, the category is still expected to deliver sustainable low single digit growth.
• Complan's dual path: The brand can still thrive by charging a premium, offering superior products, and launching products relevant for new-age consumers. Complan Viemax has been launched into the adult nutrition space via the expert route (healthcare professionals and doctors); early traction is visible with doctors prescribing it, but it is early days and still small. If the current strategy does not work, management will have to make "strategic calls at some point of time in next couple of years."
• Nutralite brand extensions: The company is leveraging the Nutralite brand to enter adjacent, larger categories as a challenger: mayonnaise (vitamin-fortified), cheese (launched in food service, early response looks good), and probiotic butter. Cheese could potentially catch up with the margarine/fat spread business but "that's a long way off."
• Market share philosophy: As market leader in most core categories (Nutralite, Sugar Free, EverYuth scrubs/peel-off, Glucon D, Nycil), management sees its role as driving category growth rather than chasing market share points. Market share is treated as a by-product of category expansion.

Tarun Arora: "Now, nutrition is something which today's consumer is very concerned and tuned on to. Having said this, consumers relevance, I mean relevance of HFD as a single source of nutrition has dialed down and people are seeking various other ways of getting nutrition and that's why this category has come under pressure."

Margins & Cost Structure

• Gross margin mechanics: Cumulative 361 bps expansion over FY'24 and FY'25 was driven by proactive strategic hedging, favorable product mix, and disciplined pricing actions despite an inflationary backdrop. The current quarter's marginal 73 bps decline at the overall level was a product mix issue: the majority of brands continued to deliver strong gross margin expansion, but the lower saliency of high-margin seasonal brands temporarily compressed the blended number.
• EBITDA margin journey: Management is on a two-year journey of enhancing EBITDA and is not moving away from that basic view. Quarter-to-quarter volatility may occur, but directionally the right actions are expected to play out. Product-by-product, SKU-by-SKU focus on gross margin expansion is in place; in a normal year, results will be as intended.
• Operating leverage thesis: As the company scales up, operating leverage will play out. The seasonal business continues to deliver double-digit growth over a 3- to 4-year period, so the basic thesis of higher growth leading to operating leverage remains intact.
• Advertisement spend: In the short to medium term, ad spend will remain at a similar level to FY'25 because the company wants to invest back and channel gross margin improvements into accelerating growth momentum. Over the longer term, more efficiencies are expected.
• Other marketing expenses: Non-traditional expenses including doctor detailing and CSD commission have increased, driven by greater presence with healthcare professionals for Sugar Free and Complan.

Tarun Arora: "To my mind, you may find a quarter here and there but directionally, we think we have taken right actions will play out."

Distribution & Channel Shifts

• Organized trade saliency jump: The share of organized trade rose from 23% to 30%, driven by two factors: the amalgamation of the Rite Bite business, which has a substantial quick commerce and e-commerce presence (more than half of the acquired business comes from e-commerce), and a mix shift as seasonal brands like Glucon D and Nycil, which have their highest share coming from rural, underperformed.
• Digital channels: Quick commerce and e-commerce continue to deliver strong growth, with Tier-2 and Tier-3 cities emerging as key growth drivers.
• Distribution expansion target: The company aims to expand Nielsen availability from 0.28 crore outlets to 0.35 crore first, and eventually to 0.4 crore outlets. It plans to add another 80,000 outlets in this financial year, with a direct distribution target of approximately 700,000 outlets by the end of FY'26.
• Rural leadership: Rural markets sustained growth leadership, outpacing urban areas, driven by strong performance in branded commodities, personal care, and daily segments.

Acquisitions & Integration

• Rite Bite (Naturell India): Post-acquisition, the business continues to outperform earlier estimates. The brand delivered robust growth, strengthening the company's position in the high-growth, better-for-you snacking category. Management stated the acquisition has been a strategically good purchase with long-term potential enhanced beyond what was imagined at the time of acquisition. The business is being liquidated into the listed company for faster integration.
• Sampriti into Nutralite convergence: The strategic call taken at the time of acquisition was to converge Sampriti into Nutralite. Nutralite's food service share remains much higher, but the retail leg is consistently expanding.
• Nutralite sourcing: Dairy sourcing is focused on western Uttar Pradesh from the Aligarh plant (dating to 1959), with its own network of societies and farmers. No sourcing issues have been seen, but pricing issues from commoditized dairy exist. Management wants to restrict dairy to the current space and does not intend to become a big dairy player.

Guidance & Commitments

Key Metrics